Efficacy of three different pulpotomy agents in primary molars: a randomized control trial

摘要: Aim To compare the clinical and radiographic efficacy of Biodentine™, ProRoot® White Mineral Trioxide Aggregate (WMTA) Tempophore™ as pulpotomy medicaments in treatment carious primary molars. Methodology A parallel-design, randomized controlled trial was developed. Patients above 3 years age with teeth vital pulps without spontaneous pain or history swelling were included. Fifty-eight patients (82 teeth) a mean 4.79 ± 1.23 years The randomized, blinded allocated to one three groups (Biodentine™, WMTA Tempophore™) for treatment. All followed up clinically radiographically (after 6, 12 18 months) by two calibrated investigators. A generalized estimating equation (GEE), Wald chi-square test an intention-to-treat analysis (ITT) ‘last carried forward’ approach performed using Statistical Package Social Sciences v 21.0 (IBM Corp., Armonk, NK, USA). Results Forty-six 69 available follow-up after 18 months. Clinical success (radiographic parenthesis) 95.24% (94.4%), 100% (90.9%) 95.65% (82.4%) groups, respectively, but difference not significant. Pulp canal obliteration significantly different amongst experimental Biodentine™ group exhibited more pulp when compared at 6 months (P = 0.008) 18 months (P = 0.003). Conclusions After 18-month follow-up, there no significant between comparison Tempophore™.